ARHGAP19 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.86549997671648E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.55999999995604E-06 |
Normal-vs-Stage2 |
1.436450E-04 |
Normal-vs-Stage3 |
1.86295423532101E-13 |
Normal-vs-Stage4 |
1.37849731629558E-11 |
Stage1-vs-Stage2 |
3.835400E-01 |
Stage1-vs-Stage3 |
2.46399999999092E-05 |
Stage1-vs-Stage4 |
5.151100E-04 |
Stage2-vs-Stage3 |
7.984000E-02 |
Stage2-vs-Stage4 |
1.418180E-01 |
Stage3-vs-Stage4 |
7.376200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.43939979327479E-10 |
Normal-vs-AfricanAmerican |
1.60640000002044E-06 |
Normal-vs-Asian |
3.288000E-01 |
Caucasian-vs-AfricanAmerican |
6.926000E-01 |
Caucasian-vs-Asian |
2.310200E-01 |
AfricanAmerican-vs-Asian |
2.199600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.44679848499163E-11 |
Normal-vs-Female |
9.84599999975799E-07 |
Male-vs-Female |
1.064160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.562730E-04 |
Normal-vs-Age(41-60Yrs) |
4.13180000213842E-08 |
Normal-vs-Age(61-80Yrs) |
3.72319952646194E-10 |
Normal-vs-Age(81-100Yrs) |
3.54719999999809E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.816600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.998600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.048400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.919200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.298000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.543800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.591000E-01 |
Normal-vs-Grade 2 |
1.59886999999692E-05 |
Normal-vs-Grade 3 |
2.91666690799275E-12 |
Normal-vs-Grade 4 |
2.56472620918657E-12 |
Grade 1-vs-Grade 2 |
1.640120E-02 |
Grade 1-vs-Grade 3 |
5.73750000000262E-05 |
Grade 1-vs-Grade 4 |
2.78919999996408E-06 |
Grade 2-vs-Grade 3 |
1.233650E-04 |
Grade 2-vs-Grade 4 |
2.16999999999024E-05 |
Grade 3-vs-Grade 4 |
2.253200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.977220E-03 |
Normal-vs-ccB subtype |
1.70041758451589E-12 |
ccA subtype-vs-ccB subtype |
3.46240003334941E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.02280001029942E-09 |
Normal-vs-N1 |
1.988730E-04 |
N0-vs-N1 |
5.180000E-01 |
|
|